IRIS
SCAVONE, Cristina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.370
AS - Asia 2.306
NA - Nord America 2.198
SA - Sud America 466
AF - Africa 31
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 10.375
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 3.812
US - Stati Uniti d'America 2.151
SG - Singapore 805
IE - Irlanda 526
CN - Cina 442
BR - Brasile 395
VN - Vietnam 369
IT - Italia 350
HK - Hong Kong 322
DE - Germania 181
GB - Regno Unito 176
KR - Corea 99
UA - Ucraina 85
IN - India 68
JP - Giappone 64
GR - Grecia 48
FI - Finlandia 34
TR - Turchia 30
AR - Argentina 26
FR - Francia 26
BD - Bangladesh 22
CA - Canada 22
SE - Svezia 18
EC - Ecuador 17
ID - Indonesia 15
MX - Messico 15
NL - Olanda 14
PL - Polonia 13
AT - Austria 12
CZ - Repubblica Ceca 12
BE - Belgio 11
IQ - Iraq 11
ZA - Sudafrica 11
CO - Colombia 10
ES - Italia 10
UZ - Uzbekistan 9
AL - Albania 7
PK - Pakistan 7
SA - Arabia Saudita 7
SC - Seychelles 7
VE - Venezuela 7
CH - Svizzera 5
CL - Cile 5
IR - Iran 5
HU - Ungheria 4
KG - Kirghizistan 4
LT - Lituania 4
NP - Nepal 4
PY - Paraguay 4
RS - Serbia 4
BG - Bulgaria 3
DK - Danimarca 3
EG - Egitto 3
JM - Giamaica 3
MA - Marocco 3
PR - Porto Rico 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
EE - Estonia 2
EU - Europa 2
GE - Georgia 2
IL - Israele 2
JO - Giordania 2
KE - Kenya 2
KW - Kuwait 2
LV - Lettonia 2
MY - Malesia 2
NO - Norvegia 2
PE - Perù 2
PH - Filippine 2
RO - Romania 2
SY - Repubblica araba siriana 2
AM - Armenia 1
AU - Australia 1
BB - Barbados 1
BH - Bahrain 1
DO - Repubblica Dominicana 1
GA - Gabon 1
HN - Honduras 1
HR - Croazia 1
IS - Islanda 1
KI - Kiribati 1
LA - Repubblica Popolare Democratica del Laos 1
MD - Moldavia 1
NG - Nigeria 1
OM - Oman 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
Totale 10.375
Salva come PNG Salva come JPEG
Città #
Moscow 1.370
Dublin 523
Singapore 401
San Jose 375
Hong Kong 318
Santa Clara 315
Chandler 195
Jacksonville 157
Ashburn 132
Ho Chi Minh City 101
Seoul 97
Beijing 73
Hanoi 71
Bremen 70
Princeton 69
Roxbury 69
Hefei 63
Dong Ket 60
Medford 46
São Paulo 41
Ann Arbor 38
The Dalles 37
Caserta 34
Aversa 32
Naples 32
Munich 30
Bengaluru 28
Dallas 24
Los Angeles 24
Napoli 24
Wilmington 24
Cambridge 23
New York 21
Da Nang 19
Orem 18
Woodbridge 18
Des Moines 17
Rio de Janeiro 16
Nuremberg 14
Nanjing 12
Salerno 12
Brno 11
Brussels 11
Falkenstein 11
Hanover 11
Helsinki 11
Milan 11
Chennai 10
London 10
Phủ Lý 10
Toronto 10
Mexico City 9
Mountain View 9
Amsterdam 8
Biên Hòa 8
Council Bluffs 8
Haiphong 8
Hải Dương 8
Jinan 8
Johannesburg 8
Tashkent 8
Atlanta 7
Brasília 7
Changsha 7
Columbus 7
Curitiba 7
Guangzhou 7
Jakarta 7
Norwalk 7
Turku 7
Warsaw 7
Boardman 6
Düsseldorf 6
Frankfurt am Main 6
Kunming 6
Manchester 6
Piracicaba 6
Redwood City 6
Rome 6
San Francisco 6
Auburn Hills 5
Baghdad 5
Belo Horizonte 5
Chicago 5
City of London 5
Dearborn 5
Guayaquil 5
Istanbul 5
New Delhi 5
Quito 5
Tirana 5
Vienna 5
Wroclaw 5
Asunción 4
Bogotá 4
Bologna 4
Dhaka 4
Groningen 4
Montreal 4
Mumbai 4
Totale 5.448
Salva come PNG Salva come JPEG
Nome #
Amelioration of diastolic dysfunction by dapagliflozin in a non-diabetic model involves coronary endothelium 195
Campania Region (Italy) spontaneous reporting system and preventability assessment through a case-by-case approach: a pilot study on psychotropic drugs 185
Contrast media-induced nephropathy: how has Italy contributed in the past 30 years? A systematic review 180
Angiotensin II and angiotensin 1-7: which is their role in atrial fibrillation? 180
Campania preventability assessment committee (Italy): A focus on the preventability of non-steroidal anti-inflammatory drugs' adverse drug reactions 177
Safety profile of anticancer and immune-modulating biotech drugs used in a real world setting in Campania Region (Italy): BIO-Cam observational study 173
Antidepressant-Induced Acute Liver Injury: A Case-Control Study in an Italian Inpatient Population 172
Dipeptidyl Peptidase 4 Inhibition Ameliorates Chronic Kidney Disease in a Model of Salt-Dependent Hypertension 164
Campania preventability assessment committee: a focus on the preventability of the contrast media adverse drug reactions 162
Adverse drug reactions during hepatitis C treatment with direct-acting antivirals: The role of medication errors, their impact on treatment discontinuation and their preventability. New insights from the Campania Region (Italy) spontaneous reporting system 158
Comparison of long-term clinical implications of beta-blockade in patients with obstructive airway diseases exposed to beta-blockers with different β1-adrenoreceptor selectivity: An Italian population-based cohort study 156
Atomoxetine in the treatment of attention deficit hyperactivity disorder and suicidal ideation 154
Medication adherence and the use of new pharmaceutical formulations: The case of levothyroxine 152
Biosimilars in the European Union from comparability exercise to real world experience: What we achieved and what we still need to achieve 150
Effects of ranolazine in a model of doxorubicin-induced left ventricle diastolic dysfunction 143
Cardiac Events Potentially Associated to Remdesivir: An Analysis from the European Spontaneous Adverse Event Reporting System 141
Neurological Manifestations Related to Immune Checkpoint Inhibitors: Reverse Translational Research by Using the European Real-World Safety Data 139
Did the new Italian law on mandatory vaccines affect adverse event Following immunization's reporting? A pharmacovigilance study in Southern Italy 139
Correction to: Angiotensin II and angiotensin 1–7: which is their role in atrial fibrillation? (Heart Failure Reviews, (2020), 10.1007/s10741-020-09961-9) 139
Pregnancy Recommendations Solely Based on Preclinical Evidence Should Be Integrated with Real-World Evidence: A Disproportionality Analysis of Certolizumab and Other TNF-Alpha Inhibitors Used in Pregnant Patients with Psoriasis 138
Can causality assessment fulfill the new European definition of adverse drug reaction? A review of methods used in spontaneous reporting( 137
Current pharmacological treatments for COVID-19: What's next? 137
Skin Toxicities Associated with Botulin Toxin Injection for Aesthetic Procedures: Data from the European Spontaneous Reporting System 134
Disclosing negative trial results – procedure 132
The importance of Pharmacovigilance for the drug safety: Focus on cardiovascular profile of incretin-based therapy 129
Hypogammaglobulinemia in patients with multiple sclerosis receiving disease modifying therapies: disproportionality analysis using the EudraVigilance database 126
Changes in Anthropometric Parameters After Anti-TNFα Therapy in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis 126
Mid-term follow-up after COVID-19 vaccination in adults with CHD: a prospective study 125
Blood-based PD-L1 analysis in tumor-derived extracellular vesicles: Applications for optimal use of anti-PD-1/PD-L1 axis inhibitors 123
The Potential Benefits of a Novel Food Supplement Based on Cannabis Sativa, Boswellia, and Fish Oil for Pain and Inflammation in Physical Activity: Unraveling the Role of Orexin-A Modulation 122
Hepatobiliary Adverse Reactions during Treatment with Cladribine: Analysis of Data from the European Spontaneous Reporting System 121
Disclosure of negative trial results. A call for action 120
The Role of Renin-Angiotensin-Aldosterone System in the Heart and Lung: Focus on COVID-19 119
Efficacy and safety of insulin-GLP-1 receptor agonists combination in type 2 diabetes mellitus: a systematic review 116
T-cell malignancies following CAR T-Cell therapy: insights from the FDA Adverse Event Reporting System (FAERS) 115
Disproportionality analysis of European safety reports on autoimmune and rheumatic diseases following COVID-19 vaccination 115
Combining liquid biopsy and radiomics for personalized treatment of lung cancer patients. State of the art and new perspectives 115
Gender differences in outpatient pediatric drug utilization: A cohort study from southern Italy 113
The Safety Profile of COVID-19 Vaccines in Patients Diagnosed with Multiple Sclerosis: A Retrospective Observational Study 112
Lymphopenia associated with sphingosine 1-phosphate receptor modulators (S1PRMs) in multiple sclerosis: analysis of European pharmacovigilance data 112
New era in treatment options of chronic hepatitis C: focus on safety of new direct-acting antivirals (DAAs) 112
Safety of dapagliflozin and empagliflozin in cases with diabetes mellitus or/and heart failure: a retrospective pharmacovigilance study conducted on the eudravigilance database 111
Association between the glyco-metabolic adverse effects of antipsychotic drugs and their chemical and pharmacological profile: A network meta-analysis and regression 111
PCSK9 Inhibitors and Neurocognitive Adverse Drug Reactions: Analysis of Individual Case Safety Reports from the Eudravigilance Database 111
Severe Multiple Sclerosis Relapse After COVID-19 Vaccination: A Case Report 110
Influenza vaccine hesitancy in patients with multiple sclerosis: A monocentric observational study 109
The Use of Botulinum Toxin Type A and the Occurrence of Anaphylaxis: A Descriptive Analysis of Data from the European Spontaneous Reporting System 107
New and old roles of the peripheral and brain renin–angiotensin–aldosterone system (RAAS): Focus on cardiovascular and neurological diseases 106
Preventable statin adverse reactions and therapy discontinuation. What can we learn from the spontaneous reporting system? 106
Immune Checkpoint Inhibitors and Immune-Related Adverse Drug Reactions: Data From Italian Pharmacovigilance Database 105
Therapeutic strategies to fight COVID-19: Which is the status artis? 105
Parental vaccine hesitancy: Recent evidences support the need to implement targeted communication strategies 104
Drugs approved for the treatment of multiple sclerosis: review of their safety profile 104
Pillars and Pitfalls of the New Pharmacovigilance legislation: Consequences for the identification of adverse drug reactions deriving from abuse, misuse, overdose, occupational exposure, and medication errors 103
Safety of Anticancer Agents Used in Children: A Focus on Their Off-Label Use Through Data From the Spontaneous Reporting System 102
Comparison of injective related reactions following ofatumumab and ocrelizumab in patients with multiple sclerosis: data from the European spontaneous reporting system 101
Two Unexpected Cases of Rosacea during Fingolimod Therapy 101
Renin-angiotensin system and coronavirus disease 2019: A narrative review 101
No substantial gender differences in suspected adverse reactions to ACE inhibitors and ARBs: results from spontaneous reporting system in Campania Region 100
Drugs-induced pathological gambling: An analysis of italian spontaneous reporting system 100
Disease-modifying therapies and hematological disorders: a systematic review of case reports and case series 99
Strengths, weaknesses and future challenges of biosimilars’ development. An opinion on how to improve the knowledge and use of biosimilars in clinical practice 99
Mineralocorticoid receptor antagonists in heart failure with preserved ejection fraction (HFpEF) 98
Surveillance of adverse events following immunization related to human papillomavirus vaccines: 12 years of vaccinovigilance in Southern Italy 98
Quinolones-Induced Musculoskeletal, Neurological, and Psychiatric ADRs: A Pharmacovigilance Study Based on Data From the Italian Spontaneous Reporting System 97
Tisagenlecleucel in children and young adults: Reverse translational research by using real‐world safety data 96
SGLT-2 inhibitors reduce the risk of cerebrovascular/cardiovascular outcomes and mortality: A systematic review and meta-analysis of retrospective cohort studies 96
The European clinical trials regulation (No 536/2014): changes and challenges 95
Immune Checkpoint Inhibitors and Cardiotoxicity: An Analysis of Spontaneous Reports in Eudravigilance 95
Hypernatremia During Intravenous Treatment With Fosfomycin: A Retrospective Medical Record Review Study and an Analysis of Spontaneous Reports in the EudraVigilance Database 94
Preventable cases of oral anticoagulant-induced bleeding: Data from the spontaneous reporting system 94
Anti-hypertensive drugs deprescribing: an updated systematic review of clinical trials 94
Suspected adverse reactions to contrast media in Campania Region (Italy): Results from 14 years of post-marketing surveillance 93
Response to the comment “Is SGLT2i superior to DPP4i for primary and secondary prevention of cardiovascular diseases and death in patients with type 2 diabetes?” 91
Three Doses of COVID-19 Vaccines: A Retrospective Study Evaluating the Safety and the Immune Response in Patients with Multiple Sclerosis 90
Response to the comment on “SGLT-2 inhibitors reduce the risk of cerebrovascular/cardiovascular outcomes and mortality: A systematic review and meta-analysis of retrospective cohort studies” 89
Efficacy and Safety Profile of Diclofenac/Cyclodextrin and Progesterone/Cyclodextrin Formulations: A Review of the Literature Data 87
Italian immunization goals: A political or scientific heated debate? 86
Real World Data on the Utilization Pattern and Safety Profile of Infliximab Originator Versus Biosimilars in Italy: A Multiregional Study 86
Hyponatremia following Antipsychotic Treatment: In Silico Pharmacodynamics Analysis of Spontaneous Reports from the US Food and Drug Administration Adverse Event Reporting System Database and an Updated Systematic Review 86
Vaccine Hesitancy Among Religious Groups: Reasons Underlying This Phenomenon and Communication Strategies to Rebuild Trust 85
The expanding family of c-Met inhibitors in solid tumors: a comparative analysis of their pharmacologic and clinical differences 83
Predictors of new oral anticoagulant drug initiation as opposed to warfarin in elderly adults: A retrospective observational study in Southern Italy 83
NSAIDs in patients with viral infections, including Covid-19: Victims or perpetrators? 82
The New Paradigms in Clinical Research: From Early Access Programs to the Novel Therapeutic Approaches for Unmet Medical Needs. 80
Weight and body mass index increase in children and adolescents exposed to antipsychotic drugs in non-interventional settings: a meta-analysis and meta-regression 79
SARS-Cov-2 infection: Response of human immune system and possible implications for the rapid test and treatment 78
Severe Cutaneous Adverse Drug Reactions Associated with Allopurinol: An Analysis of Spontaneous Reporting System in Southern Italy 77
The safety profile of general and local anaesthetic agents: Data collected during 20 years of spontaneous reporting activities in the campania region (southern italy) 77
On the Policy of the Italian Government in the Discovery, Development, and Access to Medicines 76
SMS-Based Active Surveillance of Adverse Events following Immunization in Children: The VigiVax Study 74
Flu vaccination in multiple sclerosis patients: a monocentric prospective vaccine-vigilance study 38
null 18
Facts and figures of the compassionate use of onco-hematological drugs from 2016 to 2021: Results from the multicentric observational study Compass-O 8
Hepatobiliary disorders and Direct-Acting Antiviral (DAA) therapies: real-world evidence and insights from the EudraVigilance database 7
Major Adverse Cardiovascular Events Related to JAK Inhibitors: A Disproportionality Analysis Using the WHO Global Individual Case Safety Database 6
Totale 10.569
Salva come PNG Salva come JPEG
Categoria #
all - tutte 33.408
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.408
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021135 0 0 0 0 0 0 0 0 0 9 57 69
2021/2022401 3 7 11 5 126 13 19 14 21 18 23 141
2022/2023981 134 36 18 60 107 59 6 47 467 4 25 18
2023/2024407 24 3 15 13 135 13 7 72 12 3 34 76
2024/20251.413 6 21 20 32 204 178 238 116 223 127 131 117
2025/20266.415 285 305 315 358 562 3.524 254 372 239 201 0 0
Totale 10.569